Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological modulation of CXCL12/CXCR4/ACKR3 for brain disorders - an overview.

Cell communication and signaling : CCS·2026
Same author

An integrated perspective on single-cell and spatial transcriptomic signatures in high-grade gliomas.

NPJ precision oncology·2025
Same author

Synaptic Vesicle Glycoprotein 2A Knockout in Parvalbumin and Somatostatin Interneurons Drives Seizures in the Postnatal Mouse Brain.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2025
Same author

Therapeutic targeting of the protein tyrosine kinase-7 in cancer: an overview.

The oncologist·2024
Same author

Development of an intraventricular adeno-associated virus-based labeling strategy for glioblastoma cells nested in the subventricular zone.

Neuro-oncology advances·2024
Same author

Patient-based multilevel transcriptome exploration highlights relevant chemokines and chemokine receptor axes in glioblastoma.

Computers in biology and medicine·2024

Related Experiment Video

Updated: May 8, 2026

Stable and Efficient Genetic Modification of Cells in the Adult Mouse V-SVZ for the Analysis of Neural Stem Cell Autonomous and Non-autonomous Effects
08:48

Stable and Efficient Genetic Modification of Cells in the Adult Mouse V-SVZ for the Analysis of Neural Stem Cell Autonomous and Non-autonomous Effects

Published on: February 17, 2016

Expression of SV2 isoforms during rodent brain development.

Julie Crèvecœur1, Patrik Foerch, Melissa Doupagne

  • 1Laboratory of Developmental Neurobiology, GIGA-Neurosciences, University of Liege, Sart Tilman Liege B-4000, Belgium. Bernard.Rogister@ulg.ac.be.

BMC Neuroscience
|August 14, 2013
PubMed
Summary

Synaptic vesicle glycoprotein 2A (SV2A) and SV2B expression in the hippocampus increases around postnatal day 7, coinciding with seizure onset in SV2A knockout mice, suggesting SV2A

More Related Videos

The "Brain Milking" Method for the Isolation of Neural Stem Cells and Oligodendrocyte Progenitor Cells from Live Rats
06:52

The "Brain Milking" Method for the Isolation of Neural Stem Cells and Oligodendrocyte Progenitor Cells from Live Rats

Published on: February 9, 2024

Dissection of Adult Mouse Stria Vascularis for Single-Nucleus Sequencing or Immunostaining
08:51

Dissection of Adult Mouse Stria Vascularis for Single-Nucleus Sequencing or Immunostaining

Published on: April 21, 2023

Related Experiment Videos

Last Updated: May 8, 2026

Stable and Efficient Genetic Modification of Cells in the Adult Mouse V-SVZ for the Analysis of Neural Stem Cell Autonomous and Non-autonomous Effects
08:48

Stable and Efficient Genetic Modification of Cells in the Adult Mouse V-SVZ for the Analysis of Neural Stem Cell Autonomous and Non-autonomous Effects

Published on: February 17, 2016

The "Brain Milking" Method for the Isolation of Neural Stem Cells and Oligodendrocyte Progenitor Cells from Live Rats
06:52

The "Brain Milking" Method for the Isolation of Neural Stem Cells and Oligodendrocyte Progenitor Cells from Live Rats

Published on: February 9, 2024

Dissection of Adult Mouse Stria Vascularis for Single-Nucleus Sequencing or Immunostaining
08:51

Dissection of Adult Mouse Stria Vascularis for Single-Nucleus Sequencing or Immunostaining

Published on: April 21, 2023

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Developmental Biology

Background:

  • Synaptic vesicle glycoprotein 2 (SV2) proteins (SV2A, SV2B, SV2C) are related to the major facilitator superfamily and influence neurotransmitter release.
  • SV2A is the molecular target of the anti-epileptic drug levetiracetam.
  • SV2A knockout mice exhibit seizures around postnatal day 7 (P7).

Purpose of the Study:

  • To precisely analyze and quantify SV2A, SV2B, and SV2C expression during mouse brain development.
  • To understand the role of these proteins in brain development and their impact on epileptic seizures.

Main Methods:

  • Immunohistofluorescence analysis of SV2A, SV2B, and SV2C expression from embryonic day 12 (E12) to P30.
  • Quantitative analysis using laser microdissection, qRT-PCR, and Western blot on hippocampus samples.

Main Results:

  • SV2A and SV2B expression in the hippocampus increased between P5 and P7, stabilizing by P10.
  • The increase in SV2A expression at P7 was primarily in the CA1 region, while SV2B remained stable.
  • SV2C expression patterns were not detailed in the provided abstract excerpt.

Conclusions:

  • Altered SV2A expression in the hippocampus correlates with seizure onset in SV2A knockout mice around P7.
  • This supports the hypothesis that SV2A deficiency contributes to early-onset epileptic seizures.